Open Beta
MetriLume

US marketsRNXT

SEC-sourced researchBeta

RNXT

RenovoRx, Inc.

Company comparison ↗

Data passport

CIK
0001574094
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 43,000.0000 USD; December 2025: 1,123,000.0000 USD1.1M USD0 USD0December 2024December 2025
RNXT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202443,000.0000Mar 30, 2026
December 20251,123,000.0000Mar 30, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,123,000.0000-11,168,000.0000-10,973,000.00008,095,000.00002,673,000.0000Mar 30, 2026
December 202443,000.0000-8,814,000.0000-9,125,000.00008,118,000.00003,640,000.0000Mar 30, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$1.12MDecember 2025Mar 30, 202610-K
Previous period revenueRevenues$43KDecember 2024Mar 30, 202610-K
Net incomeNetIncomeLoss-$11.17MDecember 2025Mar 30, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$10.97MDecember 2025Mar 30, 202610-K
Total assetsAssets$8.1MDecember 2025Mar 30, 202610-K
Total liabilitiesLiabilities$2.67MDecember 2025Mar 30, 202610-K

New filings

Explore methodology ↗